Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis


KILIÇ L., KÜÇÜKŞAHİN O., ÖZBALKAN Z., BES C., YAZISIZ V., YAZICI A. , ...More

ACR/ARHP 2017, SAN DİEGO, United States Of America, 3 - 08 November 2017 identifier

  • Publication Type: Conference Paper / Summary Text
  • City: SAN DİEGO
  • Country: United States Of America